235 related articles for article (PubMed ID: 24237936)
1. Dual-acting stapled peptides target both HIV-1 entry and assembly.
Zhang H; Curreli F; Waheed AA; Mercredi PY; Mehta M; Bhargava P; Scacalossi D; Tong X; Lee S; Cooper A; Summers MF; Freed EO; Debnath AK
Retrovirology; 2013 Nov; 10():136. PubMed ID: 24237936
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain.
Zhang H; Curreli F; Zhang X; Bhattacharya S; Waheed AA; Cooper A; Cowburn D; Freed EO; Debnath AK
Retrovirology; 2011 May; 8():28. PubMed ID: 21539734
[TBL] [Abstract][Full Text] [Related]
3. A cell-penetrating helical peptide as a potential HIV-1 inhibitor.
Zhang H; Zhao Q; Bhattacharya S; Waheed AA; Tong X; Hong A; Heck S; Curreli F; Goger M; Cowburn D; Freed EO; Debnath AK
J Mol Biol; 2008 May; 378(3):565-80. PubMed ID: 18374356
[TBL] [Abstract][Full Text] [Related]
4. Antiviral Activity of Dual-acting Hydrocarbon-stapled Peptides against HIV-1 Predominantly Circulating in China.
Wang Y; Curreli F; Xu WS; Li ZP; Kong S; Ren L; Hong KX; Jiang SB; Shao YM; Debnath AK; Ma LY
Biomed Environ Sci; 2017 Jun; 30(6):398-406. PubMed ID: 28705263
[TBL] [Abstract][Full Text] [Related]
5. Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators.
Zhang S; Holmes AP; Dick A; Rashad AA; Enríquez Rodríguez L; Canziani GA; Root MJ; Chaiken IM
Retrovirology; 2021 Oct; 18(1):31. PubMed ID: 34627310
[TBL] [Abstract][Full Text] [Related]
6. Design of antiviral stapled peptides containing a biphenyl cross-linker.
Muppidi A; Zhang H; Curreli F; Li N; Debnath AK; Lin Q
Bioorg Med Chem Lett; 2014 Apr; 24(7):1748-51. PubMed ID: 24613163
[TBL] [Abstract][Full Text] [Related]
7. Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein.
Lemke CT; Titolo S; von Schwedler U; Goudreau N; Mercier JF; Wardrop E; Faucher AM; Coulombe R; Banik SS; Fader L; Gagnon A; Kawai SH; Rancourt J; Tremblay M; Yoakim C; Simoneau B; Archambault J; Sundquist WI; Mason SW
J Virol; 2012 Jun; 86(12):6643-55. PubMed ID: 22496222
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of a hydrocarbon stapled peptide inhibitor in complex with monomeric C-terminal domain of HIV-1 capsid.
Bhattacharya S; Zhang H; Debnath AK; Cowburn D
J Biol Chem; 2008 Jun; 283(24):16274-8. PubMed ID: 18417468
[TBL] [Abstract][Full Text] [Related]
9. HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor.
Bashir T; Patgaonkar M; Kumar SC; Pasi A; Reddy KV
PLoS One; 2015; 10(4):e0124839. PubMed ID: 25915507
[TBL] [Abstract][Full Text] [Related]
10. Residues in the HIV-1 capsid assembly inhibitor binding site are essential for maintaining the assembly-competent quaternary structure of the capsid protein.
Bartonova V; Igonet S; Sticht J; Glass B; Habermann A; Vaney MC; Sehr P; Lewis J; Rey FA; Kraüsslich HG
J Biol Chem; 2008 Nov; 283(46):32024-33. PubMed ID: 18772135
[TBL] [Abstract][Full Text] [Related]
11. Naturally occurring variability in the envelope glycoprotein of HIV-1 and development of cell entry inhibitors.
Brower ET; Schön A; Freire E
Biochemistry; 2010 Mar; 49(11):2359-67. PubMed ID: 20166763
[TBL] [Abstract][Full Text] [Related]
12. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG
PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621
[TBL] [Abstract][Full Text] [Related]
13. Activity of the small modified amino acid alpha-hydroxy glycineamide on in vitro and in vivo human immunodeficiency virus type 1 capsid assembly and infectivity.
Abdurahman S; Végvári A; Youssefi M; Levi M; Höglund S; Andersson E; Horal P; Svennerholm B; Balzarini J; Vahlne A
Antimicrob Agents Chemother; 2008 Oct; 52(10):3737-44. PubMed ID: 18644965
[TBL] [Abstract][Full Text] [Related]
14. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
[TBL] [Abstract][Full Text] [Related]
15. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.
Curreli F; Haque K; Xie L; Qiu Q; Xu J; Yong W; Tong X; Debnath AK
Bioorg Med Chem; 2015 Dec; 23(24):7618-28. PubMed ID: 26602829
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Escape from a Peptidic Anchor Inhibitor through Stabilization of the Envelope Glycoprotein Spike.
Eggink D; de Taeye SW; Bontjer I; Klasse PJ; Langedijk JPM; Berkhout B; Sanders RW
J Virol; 2016 Dec; 90(23):10587-10599. PubMed ID: 27654295
[TBL] [Abstract][Full Text] [Related]
18. Structural determinants for affinity enhancement of a dual antagonist peptide entry inhibitor of human immunodeficiency virus type-1.
Gopi H; Umashankara M; Pirrone V; LaLonde J; Madani N; Tuzer F; Baxter S; Zentner I; Cocklin S; Jawanda N; Miller SR; Schön A; Klein JC; Freire E; Krebs FC; Smith AB; Sodroski J; Chaiken I
J Med Chem; 2008 May; 51(9):2638-47. PubMed ID: 18402432
[TBL] [Abstract][Full Text] [Related]
19. High-Mannose Specific Lectin and Its Recombinants from a Carrageenophyta Kappaphycus alvarezii Represent a Potent Anti-HIV Activity Through High-Affinity Binding to the Viral Envelope Glycoprotein gp120.
Hirayama M; Shibata H; Imamura K; Sakaguchi T; Hori K
Mar Biotechnol (NY); 2016 Apr; 18(2):215-31. PubMed ID: 26661793
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation.
Rosemary Bastian A; Nangarlia A; Bailey LD; Holmes A; Kalyana Sundaram RV; Ang C; Moreira DR; Freedman K; Duffy C; Contarino M; Abrams C; Root M; Chaiken I
J Biol Chem; 2015 Jan; 290(1):529-43. PubMed ID: 25371202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
